ASCO GU Conference Coverage
Featured Articles
(CNN) Feb 16, 2019 - The way doctors typically approach kidney cancer treatment could be evolving. Two separate studies published Saturday in the New England Journal of Medicine showed that renal cell cancer patients had significantly better outcomes when their treatment combined the targeted therapy drug axitinib, or Inlyta, with an...
Read Article
(Reuters) Feb 16, 2019 - A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Saturday. Nearly 90 percent of patients who received the...
Read Article
Latest Articles
March 15, 2019
February 22, 2019
February 19, 2019
February 19, 2019
February 19, 2019
February 19, 2019
February 19, 2019
February 19, 2019
View More
News Commentary
Editor Image
22 Feb, 2019 | by Howard Sandler, MD, MS, FASTRO
The PACE (Prostate Advances in Comparative Evidence) trial with two...
View Comment
Editor Image
13 Feb, 2019 | by Tomasz M. Beer, MD
As contemporary hormonal agents are increasingly used earlier in prostate...
View Comment
View More
OBR Blog
As the Genitourinary Cancers (GU) Symposium gets under way in San Francisco February 13-16 2019, at a pre-meeting... Read more
February 11, 2019
On the eve of the 2018 Genitourinary Cancers Symposium to be held in San Francisco February 8-10, a pre-meeting... Read more
February 05, 2018

OBR Tweets

Mar 26
Howard S. Hochster, MD: There is no question that SARS-CoV-2 will prove to be a major challenge to all health care… https://t.co/EyJijktM68

Mar 25
OBR speaks to providers at community oncology practices like Florida Cancer Specialists & Research Institute (FCS)… https://t.co/3qyne3w9gE

Mar 25
Dr. David Penson of Vanderbilt University Medical Center @VUmedicine delves into Financial toxicity and its negativ… https://t.co/o2IUnKvcff

Mar 25
Dr. Azra Raza @AzraRazaMD, an Oncologist at @Columbia, speaks to us about her recently published book @thefirstcell… https://t.co/x1HmTvHta7

Mar 25
H. Jack West, MD: An excellent piece that highlights what the history of cancer research should be teaching the wor… https://t.co/QAEpZJP8ov

Mar 24
Preparing your Oncology Clinic for COVID-19 Infections - Webinar Archive Now Available https://t.co/CV2a4q4DUl ft.… https://t.co/KvibaK0WdL

Mar 18
H. Jack West, MD: The CASPIAN trial was positive for a survival benefit with durvalumab added to platinum/etoposide… https://t.co/gdMU91vjN1

Mar 16
William McGivney, PhD: I know that I quoted that health care policy sage, Yogi Berra, a few commentaries ago, but h… https://t.co/h1xFemYuf9

Mar 13
Melody Chang, RPh, MBA, BCOP, of Florida Cancer Specialists elaborates on 340B's affect on pharmacy operations at F… https://t.co/RcEJlDtAhw

Mar 10
Gitesh Patel, of @SPACChronicCare on Sargas' plans to help practices with patient engagement and patient monitoring… https://t.co/ylAO3JCSeA